Redefine What’s Possible: a Potential New Treatment Paradigm for Stroke Patients
DiaMedica Therapeutics is committed to improving the lives of individuals battling serious vascular diseases by developing innovative therapies. With an initial focus on acute ischemic stroke (AIS), we are dedicated to advancing patient care through a novel approach that centers around improving collateral circulation, with the benefit of a 24-hour window following a stroke in which to initiate treatment. The stark reality is that less than 20% of stroke patients are eligible for an approved treatment in the United States today. DiaMedica’s mission is to revolutionize the treatment landscape for the 80% of patients who have been left with no therapeutic alternative.
More About DiaMedica